57.69 0.69(1.21%)09/27/2024
Sanofi (SNY)
Sanofi (SNY)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD | 09/27 17:18 | investopedia.com |
| FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease | 09/27 11:17 | benzinga.com |
| US FDA approves Sanofi-Regeneron's Dupixent for 'smoker's lung' | 09/27 09:39 | reuters.com |
| Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD | 09/27 09:35 | globenewswire.com |
| Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD | 09/27 07:00 | globenewswire.com |
| Are Investors Undervaluing Sanofi (SNY) Right Now? | 09/26 10:46 | zacks.com |
| Buy These 5 Big Drug Stocks to Boost Your Portfolio's Health | 09/26 10:41 | zacks.com |
| Press Release: Availability of the Q3 2024 Aide mémoire | 09/26 01:30 | globenewswire.com |
| Sanofi gets two bids valuing its consumer health unit at about $17 billion, Bloomberg News reports | 09/24 14:18 | reuters.com |
| Regeneron, SNY's Dupixent Get CHMP Recommendation for Label Expansion | 09/23 14:45 | zacks.com |